Christopher Adair
About
Christopher Adair is from 加拿大 安大略省. Christopher works in the following industries: "日用品", and "制药". Christopher is currently Product Development Scientist at Tilray, located in London, Ontario, Canada. In Christopher's previous role as a R&D Scientist at Tilray, Christopher worked in London, Ontario, Canada until Apr 2021. Prior to joining Tilray, Christopher was a Senior Organic Chemist at Canopy Growth Corporation and held the position of Senior Organic Chemist at Smiths Falls, Ontario, Canada. Prior to that, Christopher was a Organic Chemist at Canopy Growth Corporation, based in Smiths Falls, Ontario, Canada from Jun 2018 to Nov 2018. Christopher started working as Research Scientist II at Novartis Institutes for BioMedical Research (NIBR) in Cambridge, Massachusetts, United States in Oct 2016. From Nov 2014 to Sep 2016, Christopher was Research Scientist I at Novartis Institutes for BioMedical Research (NIBR), based in Cambridge, Massachusetts, United States.
If you’re looking for Christopher Adair's email address, you can find it on finalscout.com. Finalscout is a professional database with more than 500 million business professionals and 200 million company profiles.
Christopher Adair's current jobs
- Product development and process development lead in R&D department - Expertise in cannabinoid isolation and solid-dose formulations (e.g. tablets) - Successfully developed and commercialized 6 products sold nationally in Canada - New product ideation, prototype development and product optimization - Manufacturing process development and optimization - Create equipment and process SOPs, batch records and final product specifications - Design and execute process PQ/validation protocols - Collaborate with RA and QA departments to create edible cannabis ingredient lists and NFTs
Christopher Adair's past jobs
- R&D team lead for organic chemistry projects; managed 3 scientists - Intellectual property development; 1 provisional patent filed as primary inventor - Developed and optimized chemical reactions for cannabinoids and cannabinoid derivatives - Developed crystallization and chromatographic isolation processes for cannabinoids - Developed solid-dose cannabinoid formulations via spray drying of oil-in-water emulsions - Participated in talent recruitment process for hiring of new scientific staff
- Oncology drug discovery - Medicinal chemistry; hit-to-lead optimization of small molecule ligands - Organic chemistry; multi-step synthesis of small molecules - Purification of small molecules via chromatography (flash, RP-HPLC, SFC) - Structural characterization of small molecules via NMR, HPLC and UPLC-MS - Intellectual property development; co-inventor for 2 patents